BIOS601 Resources: Applications: HPV

[updated November 21, 2008]

  The Nobel Prize in Physiology or Medicine 2008

Finding the viral link: the story of Harald zur Hausen. CANCER WORLD JULY-AUGUST 2005, pp 32-37

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization STATEMENT ON HUMANPAPILLOMAVIRUS VACCINE - Feb 2007

Canadian Medical association Journal (CMAJ) - Aug 26, 2007

Koutsky et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.

Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65.

Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.

Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study